Global Cholesterol Test Market

Cholesterol Test Market Size, Share, Growth Analysis, By Product Type(Cholesterol Test Kits And Strips And Point-of-care (POC) Cholesterol Testing Devices.), By Test Type(Total Cholesterol Test, Lipid Profile Test, High-density Lipoprotein (HDL) Cholesterol, And Low-density Lipoprotein (LDL).), By End User(Clinics and Hospitals, Academic and Research Institutions, Home Care, And Diagnostic Centers), By Region - Industry Forecast 2024-2031

Report ID: SQMIG35A2894 | Region: Global | Published Date: May, 2024
Pages: 218 | Tables: 90 | Figures: 76

Cholesterol Test Market News

  • On Jan 18, 2024, Abbott’s Proclaim DRG neurostimulation System offers expanded MRI Access for people suffering from Chronic Pain.
  • On Jan 18, 2024, Abbott Announced the first Global Procedures in a clinical trial of its volt-pulsed field ablation system to treat patients with abnormal heart Rhythms.
  • On Feb. 13, 2024, Quest Diagnostics Debuts the MelaNodal Predict™ Test, Personalizing Melanoma Risk Prediction to Help Patients Forgo Invasive Surgery.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Cholesterol Test Market was valued at USD 6.8 Billion in 2022 and is poised to grow from USD 7.37 Billion in 2023 to USD 12.96 Billion by 2031 at a CAGR of 8.4% during the forecasted period (2024-2031).

The global cholesterol test market is marked by intense competition among key players, each employing distinct strategies to gain a competitive edge. Companies such as Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Thermo Fisher Scientific, and Beckman Coulter are prominent contenders in this space. These companies often focus on innovation as a key market strategy, investing heavily in research and development to introduce advanced cholesterol testing solutions. By continuously enhancing accuracy, speed, and user-friendliness of their products, they aim to capture a larger share of the market. 'Abbot Laboratories', 'Roche Diagnostics', 'Siemens Healthineers', 'Danaher Corporation', 'Quest Diagnostics', 'Eurofins Scientific', 'PTS Diagnostics', 'Randox Laboratories', 'Bio- Rad Laboratories', 'SpectraCell Laboratories, Inc.', 'Thermo Fisher Scientific', 'Cell Biolabs, Inc.', 'Beckman Coulter', 'Abcam plc', 'BioMérieux', 'Ortho Clinical Diagnostics', 'Sekisui Diagnostics', 'Tosoh Bioscience', 'Diazyme Laboratories', 'ARKRAY, Inc.'

Cardiovascular diseases, including heart disease and stroke, remain the leading causes of morbidity and mortality worldwide. The need for cholesterol testing as part of cardiovascular risk assessment drives demand for cholesterol testing products and services.

The market has seen a shift towards more advanced cholesterol testing technologies. Innovations such as point-of-care testing devices, non-invasive testing methods, and high-sensitivity assays are enhancing the accuracy, efficiency, and accessibility of cholesterol testing. Integration of cholesterol testing with digital health solutions, electronic health records (EHRs), and telemedicine platforms is also a notable trend. This integration enables remote monitoring, data management, and patient engagement, enhancing the efficiency and effectiveness of cholesterol management in various healthcare settings.

North America dominates the cholesterol testing market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the increasing geriatric population, due to which the number of patients with cholesterol has subsequently increased in this region. North America boasts advanced healthcare systems with well-established infrastructure, including hospitals, clinics, diagnostic laboratories, and healthcare providers. This infrastructure supports widespread access to cholesterol testing services. With significant investments in research and development (R&D) and healthcare technology startups. This region is at the forefront of developing and commercializing advanced cholesterol testing technologies, including point-of-care devices, non-invasive testing methods, and digital health solutions.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Feedback From Our Clients

Global Cholesterol Test Market

Report ID: SQMIG35A2894

$5,300
BUY NOW GET FREE SAMPLE